Novel methods for detecting epistasis in pharmacogenomics studies
Related Experiment Video
Updated: Jul 11, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Alison A Motsinger1, Marylyn D Ritchie, David M Reif
1North Carolina State University, Bioinformatics Research Center, Department of Statistics, Raleigh, NC 27695, USA.
Abstract:
The importance of gene-gene and gene-environment interactions in the underlying genetic architecture of common, complex phenotypes is gaining wide recognition in the field of pharmacogenomics. In epidemiological approaches to mapping genetic variants that predict drug response, it is important that researchers investigate potential epistatic interactions. In the current review, we discuss data-mining tools available in genetic epidemiology to detect such interactions and appropriate applications. We survey several classes of novel methods available and present an organized collection of successful applications in the literature. Finally, we provide guidance as to how to incorporate these novel methods into a genetic analysis. The overall goal of this paper is to aid researchers in developing an analysis plan that accounts for gene-gene and gene-environment in their own work.
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics and Pharmacogenomics: Overview
Principles of Pharmacogenetics: Types of Genetic Variants
Epistasis Analysis
Pharmacogenetics of Drug Metabolism: Overview
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

